Amneal Pharmaceuticals LLC.
Company Snapshot
Founded: 2002
Entity Type: Public
Employees: 8,500
Region: U.S.
Revenue: $3,018.8 Millions
Revenue Year: 2025
Headquarter: New Jersey, U.S.
Key Geographics: U.S., Europe, South East Asia, Middle East and Africa
Corporate Address: 400 Crossing Boulevard, Bridgewater, New Jersey 08807 U.S. Tel. +1-908-947-3120 www.amneal.com
Company Overview
Amneal Pharmaceuticals LLC., a biopharmaceutical manufacturer, develops, manufactures, markets, and distributes various necessary medications. It operates through three segments: affordable medicines, specialty, and AvKARE. Injectables, biosimilars, and retail generics are all part of the affordable medicines division. It offers a range of branded medications in its specialty category for the treatment of endocrine and central nervous system conditions. It distributes drugs and other goods to the federal government, retail, and institutional sectors in the U.S. through its AvKARE division. Its primary markets include the U.S., India, and Ireland.
Financial Highlights (FY 2025)
Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***
This information is available for BCC Research members only.
Amneal Pharmaceuticals LLC. In Reports
Company's Business Segments
- Affordable Medicines : Affordable Medicines Segment Includes Retail Generics, Injectables, And Biosimilars.
- Specialty : Offer a Portfolio of Branded Pharmaceuticals Focused Primarily on Central Nervous System and Endocrine Disorders.
- AvKARE : Distributor of Pharmaceuticals and Other Products For The U.S. Federal Government, Retail, Institutional Markets.
Applications/End User Industries
- Pharmaceutical
- Hospitals
- Healthcare
- Generics
- Biosimilars
- Central Nervous System
- Endocrine Disorders
- Injectables
- Life Sciences